Roche’s TNKase — First New Acute Ischemic Stroke Drug...

added blog Health

2025-08-18 14:25:19 -

Roche’s TNKase — First New Acute Ischemic Stroke Drug in Nearly 30 Years

Roche, a leading healthcare company specializing in thrombosis and stroke prevention, has reached a landmark achievement with the FDA approval of TNKase (tenecteplase) for acute ischemic stroke (AIS). This makes TNKase (tenecteplase) the first new stroke therapy introduced in almost three decades. Developed by Genentech, a member of the Roche Group, TNKase (tenecteplase) provides a...

0 Comments 0 Shares 39 Views 0 Reviews